BACKGROUND Tackling problematic polypharmacy requires tailoring the use of medicines
to individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Background: Knowing the barriers/enablers to deprescribing in people with a life-limiting
disease is crucial for the development of successful deprescribing interventions. These …

PURPOSE Avoidable hospitalizations due to adverse drug events and high-risk prescribing
are common in older people. Primary care physicians prescribe most on-going medicines …

Aims The aim of this systematic review was to explore health care professionals' attitudes
towards deprescribing in older people with limited life expectancy. Methods A systematic …

Abstract Background General practitioners (GPs) should regularly review patients'
medications and, if necessary, deprescribe, as inappropriate polypharmacy may harm …

Purpose This study aimed to explore the physician's knowledge and identify the perceived
barriers that prevent family medicine physicians from engaging in deprescribing among …

Introduction older adults are at risk of adverse outcomes due to a high prevalence of
polypharmacy and potentially inappropriate medications (PIMs). Deprescribing interventions …

Background Polypharmacy is an increasing problem, leading to increased morbidity and
mortality, especially in older, multimorbid patients. Consequently, there is a need for …

Objective: To estimate the prevalence of polypharmacy, describe the pharmacotherapeutic
classes used, and investigate whether polypharmacy is associated with demographic and …

Background Within the EU-funded project PRIMA-eDS (P olypharmacy in chronic diseases:
R eduction of I nappropriate M edication and A dverse drug events in older populations by e …